Payment overview · 2025
General Payments
$14.65
1 reported records · 1 companies
Healthcare provider profile · identity verified
Kenneth Edwin Marshall, MD
Allopathic & Osteopathic Physicians|Family Medicine · SHELBYVILLE, KY · NPI 1689952772
Verified facts
What the public records show
CMS Open Payments records show Kenneth Edwin Marshall, MD received $14.65 in general payments during 2025 across 1 reported records.
Exact Sciences Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $14.65 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $14.65 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $14.65 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 402 | 58 |
| Atorvastatin Calcium | Atorvastatin Calcium | 329 | 83 |
| Omeprazole | Omeprazole | 291 | 75 |
| Levothyroxine Sodium | Levothyroxine Sodium | 289 | 73 |
| Lisinopril | Lisinopril | 283 | 73 |
| Amlodipine Besylate | Amlodipine Besylate | 232 | 56 |
| Furosemide | Furosemide | 193 | 55 |
| Metoprolol Succinate | Metoprolol Succinate | 186 | 41 |
| Pantoprazole Sodium | Pantoprazole Sodium | 174 | 46 |
| Metformin Hcl Er | Metformin Hcl | 163 | 43 |
| Potassium Chloride | Potassium Chloride | 154 | 30 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 149 | 44 |
| Alprazolam | Alprazolam | 135 | 24 |
| Clopidogrel | Clopidogrel Bisulfate | 125 | 30 |
| Carvedilol | Carvedilol | 124 | 30 |
| Losartan Potassium | Losartan Potassium | 114 | 28 |
| Metformin Hcl | Metformin Hcl | 108 | 29 |
| Allopurinol | Allopurinol | 107 | 24 |
| Eliquis | Apixaban | 101 | 15 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 99 | 27 |
| Montelukast Sodium | Montelukast Sodium | 98 | 25 |
| Escitalopram Oxalate | Escitalopram Oxalate | 91 | 24 |
| Tramadol Hcl | Tramadol Hcl | 89 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 88 | 23 |
| Diclofenac Sodium | Diclofenac Sodium | 85 | 21 |
| Ozempic | Semaglutide | 82 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 81 | 15 |
| Trazodone Hcl | Trazodone Hcl | 76 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 75 | 22 |
| Jardiance | Empagliflozin | 74 | 19 |
| Tamsulosin Hcl | Tamsulosin Hcl | 73 | 17 |
| Famotidine | Famotidine | 72 | 21 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 70 | 30 |
| Pregabalin | Pregabalin | 70 | 13 |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 70 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 63 | 14 |
| Mirtazapine | Mirtazapine | 63 | 12 |
| Pravastatin Sodium | Pravastatin Sodium | 62 | 23 |
| Simvastatin | Simvastatin | 61 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 59 | 47 |
| Prednisone | Prednisone | 58 | 35 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 58 | 11 |
| Bupropion Xl | Bupropion Hcl | 57 | 11 |
| Clonazepam | Clonazepam | 56 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 55 | 12 |
| Amoxicillin | Amoxicillin | 51 | 41 |
| Metoprolol Tartrate | Metoprolol Tartrate | 51 | 16 |
| Buspirone Hcl | Buspirone Hcl | 50 | 15 |
| Xarelto | Rivaroxaban | 50 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 49 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 48 | 12 |
| Azithromycin | Azithromycin | 46 | 33 |
| Fluoxetine Hcl | Fluoxetine Hcl | 46 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 45 | 11 |
| Ondansetron Odt | Ondansetron | 45 | 19 |
| Alendronate Sodium | Alendronate Sodium | 44 | suppressed |
| Glipizide | Glipizide | 42 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 42 | 14 |
| Promethazine Hcl | Promethazine Hcl | 42 | 11 |
| Glipizide Er | Glipizide | 41 | 15 |
| Warfarin Sodium | Warfarin Sodium | 41 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 40 | suppressed |
| Nystatin | Nystatin | 40 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 40 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 39 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 37 | suppressed |
| Spironolactone | Spironolactone | 36 | suppressed |
| Lovastatin | Lovastatin | 34 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 33 | suppressed |
| Synthroid | Levothyroxine Sodium | 32 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 31 | 12 |
| Farxiga | Dapagliflozin Propanediol | 31 | suppressed |
| Ibuprofen | Ibuprofen | 29 | suppressed |
| Finasteride | Finasteride | 28 | suppressed |
| Meloxicam | Meloxicam | 28 | 12 |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 27 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 27 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 26 | suppressed |
| Entresto | Sacubitril/Valsartan | 26 | suppressed |
| Fenofibrate | Fenofibrate | 26 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 26 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 26 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 21 |
| Diazepam | Diazepam | 25 | suppressed |
| Januvia | Sitagliptin Phosphate | 25 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 25 | 12 |
| Bumetanide | Bumetanide | 24 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 24 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 24 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 24 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 23 | suppressed |
| Fluconazole | Fluconazole | 23 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 23 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 22 | suppressed |
| Irbesartan | Irbesartan | 22 | suppressed |
| Levetiracetam | Levetiracetam | 22 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 22 | suppressed |
| Aripiprazole | Aripiprazole | 21 | suppressed |
| Lansoprazole | Lansoprazole | 21 | suppressed |
| Cephalexin | Cephalexin | 20 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Mounjaro | Tirzepatide | 20 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 20 | suppressed |
| Topiramate | Topiramate | 19 | suppressed |
| Valsartan | Valsartan | 19 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 18 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 18 | suppressed |
| Celecoxib | Celecoxib | 18 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Gemfibrozil | Gemfibrozil | 18 | suppressed |
| Glimepiride | Glimepiride | 18 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 18 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 17 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 16 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 15 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 15 | suppressed |
| Digoxin | Digoxin | 15 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 15 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 15 | suppressed |
| Lorazepam | Lorazepam | 15 | suppressed |
| Methylprednisolone | Methylprednisolone | 15 | 12 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | 13 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 15 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 15 | suppressed |
| Baclofen | Baclofen | 14 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 14 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 14 | suppressed |
| Memantine Hcl | Memantine Hcl | 14 | suppressed |
| Premarin | Estrogens, Conjugated | 14 | suppressed |
| Sucralfate | Sucralfate | 14 | suppressed |
| Atenolol | Atenolol | 13 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Naproxen Sodium | Naproxen Sodium | 13 | suppressed |
| Olanzapine | Olanzapine | 13 | suppressed |
| Armodafinil | Armodafinil | 12 | suppressed |
| Belsomra | Suvorexant | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 12 | suppressed |
| Ezetimibe | Ezetimibe | 12 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Roflumilast | Roflumilast | 12 | suppressed |
| Temazepam | Temazepam | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Naproxen | Naproxen | 11 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 11 | suppressed |
| Secuado | Asenapine | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $14.65 · 1 records | Exact Sciences Corporation | The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error